Abivax (ABVX) Operating Leases (2023 - 2025)
Historic Operating Leases for Abivax (ABVX) over the last 3 years, with Q3 2025 value amounting to $2.9 million.
- Abivax's Operating Leases changed N/A to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2024, which is 27299.22% up from last year.
- Per Abivax's latest filing, its Operating Leases stood at $2.9 million for Q3 2025.
- Abivax's Operating Leases' 5-year high stood at $2.9 million during Q3 2025, with a 5-year trough of $407781.2 in Q4 2023.
- In the last 3 years, Abivax's Operating Leases had a median value of $1.4 million in 2025 and averaged $1.5 million.
- Per our database at Business Quant, Abivax's Operating Leases surged by 27499.52% in 2024 and then tumbled by 4074.82% in 2025.
- Quarter analysis of 3 years shows Abivax's Operating Leases stood at $407781.2 in 2023, then surged by 275.0% to $1.5 million in 2024, then soared by 92.04% to $2.9 million in 2025.
- Its Operating Leases was $2.9 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.3 million in Q1 2025.